The Voice of the Patient report

Produced from HNF's externally-led Patient-Focused Drug Development meeting for Charcot-Marie-Tooth disease, this report distills what patients said about their symptoms, daily-life impacts, and treatment priorities into a record HNF still shares with the FDA, drug developers, and gene therapy teams. Read it below, or download the full PDF.